Projects per year
- 250 - 300 out of 502 results
Search results
-
?Pharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment response?
9/19/23 → 8/31/28
Project: Federal Funding Agencies
-
Quantitation of nutrient metabolism in brain tumor patients using advanced 13C isotopomer technology
9/1/23 → 8/31/28
Project: Federal Funding Agencies
-
Role of lipid metabolism in CD8+ T cell ferroptosis
9/19/23 → 8/31/28
Project: Federal Funding Agencies
-
-
Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors
1/1/24 → 12/31/28
Project: Federal Funding Agencies
-
Daratumab to Enhance therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
4/30/19 → 4/29/29
Project: Non Profit
-
4/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
8/1/23 → 7/31/30
Project: Federal Funding Agencies
-
A Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D in premenopausal Women at High Risk for Breast Cancer, Phase IIB
6/29/12 → 3/22/37
Project: Federal Funding Agencies
-
Gaining Efficacy Long Term:Hydrosoft and Emerging New Embolic Coil (Gel-the-nec)
1/18/10 → 6/4/37
Project: Non Profit
-
Prospective multi-center randomized double-blind trial to assess the effectiveness and safety of 12 vs 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous coronary intervention (PCI) with either drug-eluting (DES) or bar
Harvard Clinical Research Institute
6/30/10 → 11/14/37
Project: Non Profit
-
TrialNet Natural History Study of the Development of Type 1 Diabetes
9/13/10 → 1/28/38
Project: Federal Funding Agencies
-
Escalating Clopidogrel by Involving a Genetic Strategy (ELEVATE-TIMI 56)
11/10/10 → 3/27/38
Project: Non Profit
-
A Phase II/III Trial of Neoadjuvant FOLFOX w/ Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection w/ Total Mesorectal Excisio
Bernicker, E. H., Darcourt, J. & Singh, M.
6/11/13 → 6/10/38
Project: Non Profit
-
-
-
PHASE III RANDOMIZED STUDY OF SORAFENIB PLUS DOXORUBICIN VERSUS SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Bernicker, E. H., Darcourt, J. & Singh, M.
8/13/13 → 8/12/38
Project: Non Profit
-
-
RTOG-0834; RTOG-0913; RTOG-0929
Radiation Therapy Oncology Group
8/10/11 → 12/25/38
Project: Federal Funding Agencies
-
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study:A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with orwithout Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients withDefici
Abdelrahim, M., Bernicker, E. H., Darcourt, J., Heyne, K. & Singh, M.
3/1/14 → 2/28/39
Project: Non Profit
-
A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination withIntravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVACancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer.
Zaid, T., Butler, E. B., Darcourt, J., Farach, A. M., Kamat, A. A., Shkedy, C., Singh, M. & Suri, A.
3/1/14 → 2/28/39
Project: Non Profit
-
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab (IND #134427) Versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab in P
Kamat, A. A., Darcourt, J., Singh, M., Suri, A. & Zaid, T.
3/1/14 → 2/28/39
Project: Non Profit
-
-
EAY131 - Molecular Analysis for Therapy Choice (MATCH)
Bernicker, E. H., Chang, J. C., Darcourt, J., Heyne, K., Kamat, A. A., Pingali, S. R. & Singh, M.
9/20/16 → 9/20/41
Project: Federal Funding Agencies
-
A RANDOMIZED PHASE III DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OFASPIRIN AS ADJUVANT THERAPY FOR HER2 NEGATIVE BREAST CANCER: THE ABCTRIAL
Arentz, C., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
12/8/16 → 12/7/41
Project: Non Profit
-
PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED, PARALLEL-GROUP, STUDY OF AB103 AS COMPARED TO PLACEBO IN PATIENTS WITH NECROTIZING SOFT TISSUE INFECTIONS (NSTI)
Dhala, A., Martinez, S., Mobley, C. M. & Ochoa, R. A.
6/20/17 → 6/19/42
Project: Federal Funding Agencies
-
A phase III, multicenter, randomized, study of atezolizumab/placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer
Kamat, A. A., Alaniz, A., Bernicker, E. H., Darcourt, J., Heyne, K., Singh, M., Suri, A. & Zaid, T.
3/13/18 → 3/12/43
Project: Non Profit
-
Prevention of De Novo HCV with Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant
9/18/18 → 9/17/43
Project: Non Profit
-
EA5163/S1709 INSIGNA: A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non¿Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature
Bernicker, E. H., Darcourt, J. & Zhang, J.
2/28/19 → 2/27/44
Project: Non Profit
-
INTEGRATION OF IMMUNOTHERAPY INTO ADJUVANT THERAPY FOR RESECTED NSCLC: ALCHEMIST CHEMO-IO (ACCIO)
Bernicker, E. H. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
ALLIANCE A221602: OLANZAPINEWITH ORWITHOUT FOSAPREPITANT FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY (HEC): A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Darcourt, J., Bernicker, E. H., Chang, J. C., Geyer, C. E., Heyne, K. & Niravath, P. A.
3/6/20 → 3/5/45
Project: Non Profit
-
A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation
3/26/20 → 3/25/45
Project: Non Profit